Well Lead Medical Co., Ltd. (603309.SS)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap5.11B
EV5.11B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
TTM
Revenue
72.3
79.9
75.1
91.7
108.6
144.8
164.7
162.9
198.6
207.4
Revenue % Chg.
13.6%
10.6%
-6.1%
22.2%
18.4%
33.2%
13.8%
-1.1%
21.9%
33.6%
Cost of Revenue
46.3
53.2
47.0
60.4
70.4
80.7
92.6
93.9
112.8
116.1
Gross Profit
26.1
26.7
28.1
31.3
38.2
64.0
72.1
69.0
85.8
91.3
Gross Profit Margin
36.0%
33.4%
37.4%
34.1%
35.2%
44.2%
43.8%
42.4%
43.2%
44.0%
R&D Expenses
0.7
0.8
1.4
1.7
2.4
6.2
8.1
8.0
12.0
12.7
Selling, General, & Admin Expenses
5.9
7.6
9.1
10.4
14.5
21.7
17.5
24.7
26.7
27.8
Other Expenses
6.2
6.7
7.6
8.2
11.5
12.7
12.8
12.9
15.7
16.2
Operating Income
13.3
11.5
10.0
11.0
9.8
21.4
28.9
20.8
30.1
33.2
Operating Income Margin
18.5%
14.4%
13.4%
12.0%
9.0%
14.8%
17.5%
12.8%
15.2%
16.0%
Total Other Income/Expenses Net
-0.7
3.1
3.8
-0.4
0.2
0.1
-1.2
-0.4
-0.1
-0.2
Income Before Tax
12.7
14.7
13.9
10.6
10.0
21.5
27.7
20.4
30.0
33.0
Income Before Tax Margin
17.5%
18.3%
18.5%
11.5%
9.2%
14.9%
16.8%
12.5%
15.1%
15.9%
Income Tax Expense
2.8
1.4
2.4
1.8
1.8
3.4
4.4
3.7
4.1
4.8
Net Income
9.9
13.3
11.5
9.4
9.5
17.6
22.3
15.5
24.3
26.2
Net Income Margin
13.7%
16.6%
15.4%
10.2%
8.8%
12.2%
13.5%
9.5%
12.2%
12.6%
Weighted Avg. Shares Out
195.9
247.3
257.6
262.3
257.6
257.8
259.5
258.8
292.2
293.9
EPS
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
EPS % Chg.
5.9%
6.7%
-16.7%
-20.0%
3.1%
85.2%
25.5%
-30.5%
39.0%
36.4%
Weighted Avg. Shares Out Dil
195.9
247.3
257.6
262.3
257.6
257.8
259.5
258.8
292.2
293.9
EPS Diluted
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.1
Interest Income
0.0
0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.5
0.6
Interest Expense
0.5
0.1
—
1.1
0.5
2.0
1.5
1.2
1.1
1.1
EBIT
12.2
14.7
13.9
9.5
9.6
19.6
26.3
19.4
29.3
32.5
EBIT Margin
16.9%
18.4%
18.6%
10.4%
8.9%
13.6%
16.0%
11.9%
14.8%
15.7%
Depreciation & Amortization
2.2
2.5
2.8
3.1
4.2
10.3
9.2
10.4
12.8
3.1
EBITDA
14.3
17.2
16.7
12.7
13.8
30.0
35.6
29.8
42.1
35.6
EBITDA Margin
19.8%
21.5%
22.2%
13.8%
12.7%
20.7%
21.6%
18.3%
21.2%
17.2%